Picture of Biosynex SA logo

ALBIO Biosynex SA Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall Cap

Annual cashflow statement for Biosynex SA, fiscal year end - December 31st, millions except per share.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M
Source:ARSARS
Standards:
FAS
FAS
Status:
fx
Preliminary
fx
Preliminary
fx
Preliminary
FinalFinal
Net Income/Starting Line31.4107
Depreciation
Deferred Taxes
Non-Cash Items0.0010.031
Unusual Items
Changes in Working Capital-7.180.578
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities31.6110
Capital Expenditures-9.12-19
Purchase of Fixed Assets
Other Investing Cash Flow Items1.19-9.95
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-7.93-29
Financing Cash Flow Items0.154-1.78
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities10.614.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash34.395.3

Or unlock with your email

Or unlock with your email